Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

Arteris, Inc.

AIPNASDAQEQUITYCurrent

Changes in Beneficial Ownership

Filed Oct 6, 2026Accepted Oct 6, 2026, 4:19 PM EDTFiling CIK 1667011Accession 0001375414-26-000005
Share

Structured filing — 4

primarydocument.xml

Open full document ↗

Filing details

Report period
2026-10-05
Issuer
Arteris, Inc.
Issuer CIK
0001667011
Trading symbol
AIP

Reporting owner 1

Name
Kunkel Joachim
Reporting owner CIK
0001375414
Relationship
Director
Address
C/O ARTERIS, INC., 900 E. HAMILTON AVE., SUITE 300, CAMPBELL, CA, 95008

Non-derivative transactions

Non-derivative transactions · 1 reported row
SecurityTransaction dateCodeAmountA / DPrice (USD)Owned afterOwnership
Common Stock2026-10-05A · Form 4633.00[F1][F2]A0.0075,328.00D
Table key
A · Form 4
Acquisition by grant, award or otherwise under Rule 16b-3(d)
A
Acquired
D
Direct

Footnotes

F1
Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. This grant of restricted stock was made on Oct 5, 2026, based on the average trading price of Arteris, Inc. common stock for the period from August 24, 2026 through October 5, 2026, which was $22.69.↩ 1
F2
The Reporting Person elected to defer the receipt of shares.↩ 1

Signature 1

Signed
/s/ Paul Alpern, as Attorney-in-Fact for Kunkel Joachim
Date
2026-10-06

Company context

Arteris is a leading provider of semiconductor technology that accelerates the creation of high-performance, power-efficient silicon with built-in safety, reliability, and security. Innovative Arteris products are designed to optimize data movement and help ease complexity in the modern AI era with network-on-chip (NoC) interconnect intellectual property (IP), system-on-chip (SoC) software for integration automation and hardware security assurance. All are used by the world’s top technology companies to improve overall performance and engineering productivity, reduce risk, lower costs, and bring cutting-edge designs to market faster. Learn more at arteris.com.

Current securities

Historical securities (2)

Recent company filings

  1. 10-Q filingNov 5, 2026
  2. Results of Operations and Financial ConditionNov 5, 2026
  3. 4 filingNov 4, 2026
  4. 4 filingOct 6, 2026
  5. 144 filingOct 5, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.